Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 2/20 | 0.60 |
| ▸ | FGF2 | P09038 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12694970 | 1.00 | FGF1 (0.60) | FGF1FGF2 | |
| Sucrosofate SCHEMBL145069 | 0.85 | FGF1 (0.74) | FGF1FGF2 | |
| Sucrosofate SCHEMBL18467935 | 0.85 | FGF1 (0.74) | FGF1FGF2 | |
| Sucrosofate SCHEMBL16661861 | 0.85 | FGF1 (0.74) | FGF1FGF2 | |
| Sucrosofate SCHEMBL16661862 | 0.85 | FGF1 (0.74) | FGF1FGF2 | |
| Sucrosofate SCHEMBL145070 | 0.85 | FGF1 (0.74) | FGF1FGF2 | |
| Sucrosofate SCHEMBL921799 | 0.84 | FGF1 (0.72) | FGF1FGF2 | |
| Sucrosofate SCHEMBL18742107 | 0.84 | FGF1 (0.72) | FGF1FGF2 | |
| Sucrosofate SCHEMBL18244210 | 0.78 | FGF1 (0.65) | FGF1FGF2 | |
| Sucrosofate SCHEMBL19358882 | 0.78 | FGF1 (0.65) | FGF1FGF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9562065-B2 | Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical cosmetic uses of same | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2017-02-07 | — | — | US | disclosed |
| US-20120245120-A1 | ZINC SUCROSE OCTASULFATES, THEIR PREPARATION, AND PHARMACEUTICAL AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120245120-A1 | ZINC SUCROSE OCTASULFATES, THEIR PREPARATION, AND PHARMACEUTICAL AND COSMETIC USES THEREOF | SLC39A3, SLC39A7, SOD3 | FGF1 2532/4885FGF2 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.